February 2022: In This Issue

The oral tablet formulation was approved for adults with weakened immune systems who have not responded to other therapy.

Melissa McGivney, PharmD, FAPhA, FCCP, helps celebrate American Pharmacists Month and the innovation driving the profession forward amongst US communities.

Teva Pharmaceuticals’ new olanzapine option is the first once-monthly subcutaneous injectable on the market for schizophrenia.

The novel tool can be used to inform vaccine policy, monitor impact, and essentially strengthen overall surveillance.

Melissa McGivney, PharmD, FAPhA, FCCP, discusses her career journey from her local pharmacy to a national leadership role with the American Pharmacists Association.

Researchers evaluate peer-reviewed literature on interventions to improve vaccine uptake among thousands of US adults studied between 2010 and 2015.

Infectious disease readiness depends on rehearsed workflows, bidirectional public health communication, and rapid access to care.

Pharmacist pain clinics typically focus on comprehensive medication management involving the entire patient scenario.